X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-22 | GCTK | Glucotrack, Inc. | Sycoff Drew | Dir, 10% | P - Purchase | $1.26 | +182,540 | 2,951,258 | +7% | +$230,000 | ||||||
2024-04-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $7.49 | -1,184 | 306,684 | 0% | -$8,868 | ||||||
| M | 2024-04-19 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.12 | -64,653 | 3,437,322 | -2% | -$913,057 | |||||
2024-04-16 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $40.00 | -1,451 | 999,782 | 0% | -$58,040 | ||||||
| M | 2024-04-16 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -16,992 | 3,501,975 | 0% | -$238,231 | |||||
2024-04-17 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale | $230.03 | -15,000 | 30,471 | -33% | -$3,450,450 | ||||||
2024-04-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.03 | +15,363 | 15,284,431 | 0% | +$15,801 | ||||||
2024-04-15 | PETV | Petvivo Holdings, Inc. | Lai John | CEO, Pres | P - Purchase | $0.60 | +150,000 | 1,288,592 | +13% | +$90,000 | ||||||
| D | 2024-04-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $40.96 | -6,000 | 182,894 | -3% | -$245,760 | |||||
2024-04-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $137.81 | -1,990 | 42,377 | -4% | -$274,242 | ||||||
2024-04-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.06 | +3,587 | 15,269,068 | 0% | +$3,802 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale | $4.75 | -4,000 | 34,665 | -10% | -$19,000 | ||||||
2024-04-11 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $4.75 | -3,054 | 58,242 | -5% | -$14,507 | ||||||
2024-04-11 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $4.75 | -1,325 | 17,042 | -7% | -$6,294 | ||||||
| M | 2024-04-11 | NPCE | Neuropace Inc | Orbimed Advisors LLC | 10% | S - Sale | $14.49 | -485,000 | 3,518,967 | -12% | -$7,026,033 | |||||
| D | 2024-04-08 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $100.47 | -59,801 | 101,845 | -37% | -$6,008,359 | |||||
2024-04-08 | DXCM | Dexcom Inc | Sayer Kevin R | Pres CEO, COB | S - Sale | $138.30 | -49,633 | 283,893 | -15% | -$6,864,136 | ||||||
| M | 2024-04-05 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $99.91 | -1,634 | 52,532 | -3% | -$163,260 | |||||
| D | 2024-04-05 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.81 | -2,457 | 101,845 | -2% | -$237,862 | |||||
2024-04-08 | ANGO | Angiodynamics Inc | Clemmer James C | Pres, CEO | P - Purchase | $6.70 | +10,000 | 539,066 | +2% | +$67,000 | ||||||
| M | 2024-04-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.10 | +42,044 | 15,265,481 | 0% | +$46,383 | |||||
| DM | 2024-04-03 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $96.59 | -400 | 101,845 | 0% | -$38,636 | |||||
| M | 2024-04-03 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $95.03 | -750 | 54,166 | -1% | -$71,271 | |||||
| M | 2024-04-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $15.53 | -4,227 | 251,533 | -2% | -$65,652 | |||||
2024-04-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.45 | -2,425 | 205,516 | -1% | -$37,474 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $5.08 | -4,893 | 168,620 | -3% | -$24,852 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO | S - Sale | $5.08 | -12,571 | 5,750,729 | 0% | -$63,848 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.08 | -3,128 | 1,762,776 | 0% | -$15,887 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Park Sam Boong | COO | S - Sale | $5.08 | -3,414 | 261,754 | -1% | -$17,340 | ||||||
2024-04-03 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | CFO | S - Sale | $5.08 | -10,123 | 426,248 | -2% | -$51,415 | ||||||
| A | 2024-04-01 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $205.09 | -40,000 | 306,737 | -12% | -$8,203,581 | |||||
2024-04-02 | GKOS | Glaukos Corp | Thurman Alex R. | SVP, CFO | S - Sale | $90.37 | -474 | 54,916 | -1% | -$42,835 | ||||||
2024-04-01 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $205.09 | -40,000 | 306,737 | -12% | -$8,203,581 | ||||||
2024-04-01 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $217.07 | -600 | 64,281 | -1% | -$130,242 | ||||||
2024-04-01 | PEN | Penumbra Inc | Kassing Don W. | Dir | S - Sale | $223.18 | -170 | 9,675 | -2% | -$37,941 | ||||||
| D | 2024-04-01 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $213.99 | -32 | 10,900 | 0% | -$6,848 | |||||
2024-04-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.15 | +8,292 | 15,223,437 | 0% | +$9,499 | ||||||
2024-04-01 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $30.39 | -1,500 | 72,784 | -2% | -$45,585 | ||||||
| D | 2024-04-01 | BSX | Boston Scientific Corp | Sorenson John Bradley | EVP, Global Operations | S - Sale+OE | $69.30 | -16,351 | 50,638 | -24% | -$1,133,069 | |||||
| D | 2024-04-01 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale+OE | $68.42 | -6,983 | 51,068 | -12% | -$477,777 | |||||
2022-11-15 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $20.29 | -50,000 | 1,592,624 | -3% | -$1,014,692 | ||||||
2024-03-28 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $140.04 | -2,624 | 68,682 | -4% | -$367,472 | ||||||
| D | 2024-03-26 | SWAV | Shockwave Medical, Inc. | Francis Laura | Dir | S - Sale+OE | $300.00 | -1,500 | 4,784 | -24% | -$450,000 | |||||
2024-03-26 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Pres, CCO | S - Sale | $287.67 | -4,000 | 56,818 | -7% | -$1,150,680 | ||||||
| D | 2024-03-25 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $197.81 | -554 | 10,636 | -5% | -$109,587 | |||||
2024-03-26 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.18 | +5,096 | 15,215,145 | 0% | +$6,024 | ||||||
2024-03-22 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $194.40 | -4,387 | 11,270 | -28% | -$852,849 | ||||||
2024-03-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $9.36 | -1,184 | 307,868 | 0% | -$11,082 | ||||||
2024-03-25 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief HR | S - Sale | $140.00 | -4,137 | 76,304 | -5% | -$579,180 | ||||||
2024-03-25 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.20 | +1,000,000 | 61,392,221 | +2% | +$200,000 | ||||||
2024-03-25 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.21 | +3,612 | 15,210,049 | 0% | +$4,368 | ||||||
| D | 2024-03-22 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale+OE | $5.39 | -5,541 | 25,665 | -18% | -$29,853 | |||||
2024-03-20 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83,296 | -3% | -$44,511 | ||||||
2024-03-19 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.19 | +2,147 | 15,206,437 | 0% | +$2,555 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Aharon Gil | Dir | P - Purchase | $3.72 | +26,882 | 1,069,710 | +3% | +$100,001 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Salamon Steven A J | Dir | P - Purchase | $3.72 | +26,882 | 1,121,025 | +2% | +$100,001 | ||||||
2024-03-15 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $5.46 | -3,125 | 51,371 | -6% | -$17,063 | ||||||
2024-03-15 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $5.46 | -1,217 | 14,067 | -8% | -$6,645 | ||||||
| D | 2024-03-18 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $193.53 | -554 | 10,190 | -5% | -$107,216 | |||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $48.83 | -441 | 62,472 | -1% | -$21,534 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $48.83 | -1,024 | 102,149 | -1% | -$50,002 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $48.83 | -5,391 | 241,319 | -2% | -$263,243 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $48.83 | -244 | 55,860 | 0% | -$11,915 | ||||||
2024-03-18 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $41.13 | -40,000 | 1,003,296 | -4% | -$1,645,079 | ||||||
2024-03-18 | ATRC | Atricure, Inc. | Dahlquist Karl S. | GC | S - Sale | $32.16 | -1,885 | 50,954 | -4% | -$60,622 | ||||||
2024-03-15 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $51.99 | -10,590 | 17,419 | -38% | -$550,574 | ||||||
2024-03-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corp Dev | S - Sale | $130.21 | -4,203 | 44,367 | -9% | -$547,259 | ||||||
2024-03-18 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $66.45 | -14,506 | 58,098 | -20% | -$963,930 | ||||||
2024-03-15 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -1,462 | 41,121 | -3% | -$29,240 | ||||||
2024-03-15 | FNA | Paragon 28, Inc. | Dacosta Albert | see remarks, 10% | P - Purchase | $9.12 | +28,000 | 11,007,446 | 0% | +$255,226 | ||||||
2024-03-14 | ATEC | Alphatec Holdings, Inc. | Bakst Evan | Dir | P - Purchase | $13.53 | +15,000 | 1,104,038 | +1% | +$202,950 | ||||||
| D | 2024-03-13 | NVNO | Envveno Medical Corp | Alavi Hamed | CTO | S - Sale+OE | $6.22 | -8,334 | 0 | -100% | -$51,837 | |||||
2024-03-13 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale | $7.95 | -20,381 | 479,959 | -4% | -$162,029 | ||||||
| M | 2023-03-13 | UFPT | Ufp Technologies Inc | Cardin Steve | VP | S - Sale | $197.49 | -915 | 5,039 | -15% | -$180,704 | |||||
2024-03-15 | ICUI | Icu Medical Inc/de | Woolson Daniel | VP, GM-Infusion Capital | S - Sale | $98.27 | -791 | 13,980 | -5% | -$77,733 | ||||||
2024-03-14 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -3,994 | 42,583 | -9% | -$79,880 | ||||||
2024-03-14 | BDX | Becton Dickinson & Co | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $238.29 | -282 | 2,393 | -11% | -$67,198 | ||||||
2024-03-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.22 | +5,000 | 15,204,290 | 0% | +$6,096 | ||||||
| DM | 2024-03-13 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $1.99 | -42,555 | 618,750 | -6% | -$84,882 | |||||
| D | 2024-03-13 | CERS | Cerus Corp | Moore Carol | SVP Reg., Quality | S - Sale+OE | $2.02 | -20,619 | 490,623 | -4% | -$41,553 | |||||
| DM | 2024-03-13 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale+OE | $2.02 | -35,284 | 490,912 | -7% | -$71,107 | |||||
| DM | 2024-03-13 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $2.02 | -53,041 | 878,653 | -6% | -$106,892 | |||||
| DM | 2024-03-13 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale+OE | $2.04 | -125,926 | 3,181,281 | -4% | -$256,377 | |||||
| DM | 2024-03-13 | CERS | Cerus Corp | Corash Laurence M | Chief Scientific Officer | S - Sale+OE | $2.02 | -28,427 | 2,339,740 | -1% | -$57,288 | |||||
| DM | 2024-03-13 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $2.02 | -35,115 | 459,612 | -7% | -$70,766 | |||||
2024-03-12 | AORT | Artivion, Inc. | Getz Matthew A | VP, HR | S - Sale | $19.94 | -5,000 | 43,536 | -10% | -$99,720 | ||||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $20.27 | -2,134 | 137,888 | -2% | -$43,259 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,007 | 81,726 | -4% | -$60,955 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Maney Rochelle L. | VP, Quality | S - Sale | $20.27 | -2,282 | 44,518 | -5% | -$46,259 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $20.27 | -2,838 | 166,852 | -2% | -$57,529 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.27 | -2,367 | 44,580 | -5% | -$47,982 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $20.27 | -3,461 | 162,572 | -2% | -$70,158 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,261 | -1% | -$9,223 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Maney Rochelle L. | VP, Quality | S - Sale | $19.83 | -370 | 44,148 | -1% | -$7,339 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $19.83 | -421 | 44,159 | -1% | -$8,350 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $19.83 | -325 | 137,563 | 0% | -$6,446 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $19.83 | -584 | 161,988 | 0% | -$11,583 | |||||
| A | 2024-02-26 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $20.27 | -30,836 | 696,253 | -4% | -$625,080 | |||||
| A | 2024-02-27 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $19.83 | -485 | 166,367 | 0% | -$9,620 | |||||
| A | 2024-03-05 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $18.72 | -1,152 | 139,989 | -1% | -$21,568 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |